Aug 2023 Articles

Articles
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Writing Committee Members; Virani SS, Newby LK, et al.
Journal:
J Am Coll Cardiol

First published: August 29, 2023 DOI: 10.1016/j.jacc.2023.04.003
View
- Share
Articles
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Szarek M, Reijnders E, Jukema JW, et al.
Journal:
Circulation

First published: August 26, 2023 DOI: 10.1161/CIRCULATIONAHA.123.066398
View
- Share
Articles
Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association
Dennison Himmelfarb CR, Beckie TM, Allen LA, et al.
Journal:
Circulation

First published: August 14, 2023 DOI: 10.1161/CIR.0000000000001162
View
- Share
Articles
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020
Zheutlin AR, Jacobs JA, Derington CG, et al.
Journal:
J Clin Lipidol

First published: August 12, 2023 DOI: 10.1016/j.jacl.2023.08.005
View
- Share
Articles
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia
Scicali R, Bosco G, Scamporrino A, et al.
Journal:
Eur J Clin Invest

First published: August 12, 2023 DOI: 10.1111/eci.14083
View
- Share
Articles
Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review
Rahman H, Khan SU, Lone AN, et al.
Journal:
J Am Heart Assoc

First published: August 10, 2023 DOI: 10.1161/JAHA.123.030578
View
- Share
Articles
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Raschi E, Casula M, Cicero AFG, et al.
Journal:
Pharmacol Ther

First published: August 9, 2023 DOI: 10.1016/j.pharmthera.2023.108507
View
- Share
Articles
Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic study of Atherosclerosis
Harpreet S. Bhatia, Rishi Rikhi, Tara S. Allen, et al.
Journal:
Atherosclerosis

First published: August 8, 2023 DOI: 10.1016/j.atherosclerosis.2023.117217
View
- Share
Articles
Colchicine for cardiovascular prevention: the dawn of a new era has finally come
Bonaventura A, Abbate A
Journal:
Eur Heart J

First published: August 2, 2023 DOI: 10.1093/eurheartj/ehad453
View
- Share
Articles
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial
Lee SJ, Cha JJ, Choi WG, et al.
Journal:
JAMA Cardiol

First published: August 2, 2023 DOI: 10.1001/jamacardio.2023.2222
View
- Share

Aug 2023 Articles

Articles

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Writing Committee Members; Virani SS, Newby LK, et al.

Articles

Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests

Szarek M, Reijnders E, Jukema JW, et al.

Articles

Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association

Dennison Himmelfarb CR, Beckie TM, Allen LA, et al.

Articles

Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020

Zheutlin AR, Jacobs JA, Derington CG, et al.

Articles

Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia

Scicali R, Bosco G, Scamporrino A, et al.

Articles

Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review

Rahman H, Khan SU, Lone AN, et al.

Articles

Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events

Raschi E, Casula M, Cicero AFG, et al.

Articles

Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic study of Atherosclerosis

Harpreet S. Bhatia, Rishi Rikhi, Tara S. Allen, et al.

Articles

Colchicine for cardiovascular prevention: the dawn of a new era has finally come

Bonaventura A, Abbate A

Articles

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial

Lee SJ, Cha JJ, Choi WG, et al.